Orodispersible lozenges containing a combination of Lactobacillus reuteri DSM 17938 and Lactobacillus reuteri ATCC PTA 5289 and normal gum function: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006

Following an application from BioGaia AB submitted for authorisation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006 via the Competent Authority of Sweden, the EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver an opinion on the scientific...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:EFSA J
Autors principals: Turck, Dominique, Castenmiller, Jacqueline, De Henauw, Stefaan, Ildico Hirsch‐Ernst, Karen, Kearney, John, Knutsen, Helle Katrine, Maciuk, Alexandre, Mangelsdorf, Inge, McArdle, Harry J, Naska, Androniki, Pelaez, Carmen, Pentieva, Kristina, Thies, Frank, Tsabouri, Sophia, Vinceti, Marco, Bresson, Jean‐Louis, Sanz, Yolanda, Siani, Alfonso
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2020
Matèries:
Scientific Opinion
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7447865/
https://ncbi.nlm.nih.gov/pubmed/32874242
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2903/j.efsa.2020.6004
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars